germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Fundació</strong> <strong>Institut</strong> <strong>d'Investigació</strong><br />
<strong>en</strong> <strong>Ciències</strong> <strong>de</strong> la Salut<br />
Germans Trias i Pujol<br />
CLIN EXP IMMUNOL 2006; 145(3):535‐544.<br />
IF: 2,747<br />
Dra<strong>en</strong>ert R, All<strong>en</strong> TM, Liu Y, Wrin T, Chappey C, Verrill CL, Sirera G, Eldridge RL, Lahaie MP, Ruiz L, Clotet B,<br />
Petropoulos CJ, Walker BD, Martinez‐Picado J.<br />
Constraints on HIV‐1 evolution and immunodominance revealed in monozygotic adult twins infected with the<br />
same virus.<br />
J EXP MED 2006; 203(3):529‐539.<br />
IF: 14,484<br />
El‐Sadr WM, Lundgr<strong>en</strong> JD, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Coh<strong>en</strong><br />
CJ,Cohn D, Cooper D, Darbyshire J, Emery S, Fatk<strong>en</strong>heuer G, Gazzard B, Grund B, Hoy J, Klingman K, Losso M,<br />
Markowitz N, Neuhaus J, Phillips A, Rappoport C. (Strategies for Managem<strong>en</strong>t of Antiretroviral Therapy (SMART)<br />
CD4+ count‐gui<strong>de</strong>d interruption of antiretroviral treatm<strong>en</strong>t.<br />
NEW ENGL J MED 2006 Nov 30;355(22):2283‐96<br />
IF: 51,296<br />
Esté J.<br />
How to dismantle an immune response.<br />
Future Virology 2006. 1: 9‐11<br />
IF:<br />
Fernan<strong>de</strong>z G, Llano A, Esgleas M, Clotet B, Este JA, Martinez MA.<br />
Purifying selection of CCR5‐tropic human immuno<strong>de</strong>fici<strong>en</strong>cy virus type 1 variants in AIDS subjects that have<br />
<strong>de</strong>veloped syncytium‐inducing, CXCR4‐tropic viruses.<br />
J GEN VIROL 2006; 87:1285‐1294.<br />
IF: 3,11<br />
Ferraz RM, Aris A, Martinez MA, Villaver<strong>de</strong> A.<br />
High‐throughput, functional scre<strong>en</strong>ing of the anti‐HIV‐1 humoral response by an <strong>en</strong>zymatic nanos<strong>en</strong>sor.<br />
MOL IMMUNOL 2006; 43(13):2119‐2123.<br />
IF: 4,768<br />
Fox Z, Dragsted UB, Gerstoft J, Phillips AN, Kjaer J, Mathies<strong>en</strong> L, Youle M, Katlama C, Hill A, Bruun JN, Clumeck N,<br />
Dellamonica P, Lundgr<strong>en</strong> JD; The COLATE study group.<br />
A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a<br />
lamivudine‐containing regim<strong>en</strong>: the COLATE trial.<br />
ANTIVIR THER 2006;11(6):761‐70.<br />
IF: 4,982<br />
Fuster D, Planas R, Gonzalez J, Force L, Cervantes M, Vilaro J, Roget M, Garcia I, Pedrol E, Tor J, Ballesteros AL, Salas<br />
A, Sirera G, Vi<strong>de</strong>la S, Clotet B, Tural C.<br />
Results of a study of prolonging treatm<strong>en</strong>t with pegylated interferon‐alpha 2a plus ribavirin in HIV/HCV‐coinfected<br />
pati<strong>en</strong>ts with no early virological response.<br />
ANTIVIR THER 2006; 11(4):473‐482.<br />
IF: 4,982<br />
Guma M, Cabrera C, Erkizia I, Bofill M, Clotet B, Ruiz L, Lopez‐Botet M.<br />
Human cytomegalovirus infection is associated with increased proportions of NK cells that express the<br />
CD94/NKG2C receptor in aviremic HIV‐1‐positive pati<strong>en</strong>ts.<br />
J INFECT DIS 2006; 194(1):38‐41.<br />
Pàgina 53/177
Change language